Scary Recall: THESE Pills Are Too Strong!

One lot of thyroid tablets was pulled nationwide after tests showed the pills could be too strong.

Story Snapshot

Vitruvias recalled one lot of 30 mg thyroid tablets for potential superpotency.
The affected lot is 504950, NDC 69680-166-00, with a 9/30/2026 expiration date.
Superpotent tablets can trigger hyperthyroidism symptoms and heart rhythm problems.
3,655 units were released and 1,955 sold across the United States; no injuries reported to date.

Recall Details: What Was Pulled and Why It Matters

Vitruvias Therapeutics announced a voluntary recall of one lot of Thyroid Tablets, United States Pharmacopeia 30 milligrams, after testing found the potential for superpotency. The recall targets lot 504950, with National Drug Code 69680-166-00, and an expiration date of September 30, 2026.

The company reported 3,655 units released and 1,955 units sold to direct accounts nationwide from late January through September 2025. The recall is at the consumer level, which means patients should check their bottles.

Superpotent thyroid tablets can push the body into a hyperthyroid state. Patients may feel racing heartbeats, chest pain, high blood pressure, weight loss, heat intolerance, tremor, fatigue, or muscle weakness.

People with heart disease face higher risk from fast or irregular heart rhythms. The Food and Drug Administration (FDA) notice states Vitruvias has received no reports of adverse events tied to this recall as of the announcement date. That is good news, but the risk profile still warrants action.

'Superpotent' Thyroid medication recalled one month after FDA advises against similar tablets https://t.co/jGK75IOEcX pic.twitter.com/jhFrWTCro8

— New York Post (@nypost) August 25, 2026

Who Is Affected and What To Do Next

Patients taking thyroid replacement who hold this exact lot should take simple steps. Check the bottle label for Thyroid Tablets, United States Pharmacopeia 30 milligrams, National Drug Code 69680-166-00, lot 504950, expiration 9/30/2026.

If it matches, stop using the product and call your pharmacist for guidance on returns and replacement. Contact your prescriber to discuss symptoms and whether labs are needed. Do not skip thyroid medicine without a plan. Ask the pharmacy for a safe, same-strength alternative.

Pharmacies and clinics should pull stock of the affected lot and quarantine it. They should notify patients who may have received the lot based on dispensing records. Wholesalers should alert downstream accounts and track responses.

These steps are standard recall practice and help close the loop fast. The FDA recall database lists this event under potency concerns, which fall into a well-known class of quality issues across many drugs, not just thyroid products.

Why Thyroid Potency Errors Pack Extra Risk

Thyroid hormone has a narrow dosing window. Small shifts in dose can swing patients from under-treated to over-treated within days to weeks. Older adults and people with heart disease are especially sensitive to extra hormone, which can strain the heart.

Past recalls from other firms show that both low potency and high potency problems can occur and drive market actions to protect patients. This pattern explains why a single-lot issue still prompts a consumer-level recall.

Recall: Vitruvias Thyroid Tablets USP 30 mg — lot 504950, exp. 9/30/2026, NDC 69680-166-00 — for potential superpotency.

Check your bottle. If it matches, contact your pharmacy or clinician. Do not discontinue without clinician guidance.https://t.co/rRHBYf0Ump

— The Modern Bio (@themodernbio) August 26, 2026

Vitruvias framed the action as voluntary and narrow in scope, which fits the facts in the notice: one lot, defined identifiers, and no known injuries. Regulators and clinicians will focus on the confirmed risk label—superpotency—because that is what guides patient safety steps.

USA Today’s consumer brief echoes these identifiers, helping readers match labels and act quickly. That balance makes sense. Move fast to prevent harm, then let routine follow-up confirm that returns and notices reached the right people.